The Boeing CompanyPentagon selected Boeing to develop the Navy's F/A-XX fighter under a contract valued at more than $20 billion, beating Northrop Grumman.
Boeing surged 3% in premarket trading to $193.41 after the Pentagon selected the aerospace giant to develop the U.S. Navy's next-generation carrier-based strike fighter, the F/A-XX, under a contract valued at more than $20 billion. The award, which beat out rival Northrop Grumman, marks Boeing's second consecutive sixth-generation fighter program win and places the company at the center of the Navy's Next Generation Air Dominance initiative. Concentrix plunged 11.1% to $22.11 after reporting fiscal third-quarter revenue of $2.45 billion, down 1.2% year over year and about $30 million short of expectations, and guiding fourth-quarter revenue down 3% to 5% on a constant-currency basis while cutting its full-year 2026 revenue outlook to $9.827 billion-$9.877 billion. Moderna fell 6.3% after Citi downgraded the biotechnology company to Sell and raised its price target to $80 from $60, saying the valuation had become stretched following a run to a new 52-week high of $208.90. GameStop rose 1.6% after CEO Ryan Cohen disclosed an open-market purchase of 450,000 Class A shares on Sept. 29 for about $10.6 million, lifting his total beneficial ownership to 44.68 million shares, or about 8.8% of the company. Yiren Digital rose 6.1% despite reporting a GAAP loss of 75 cents per share and revenue of about $131.2 million, down roughly 43% year over year, as investors focused on a sequential narrowing of the net loss.
The Boeing CompanyPentagon selected Boeing to develop the Navy's F/A-XX fighter under a contract valued at more than $20 billion, beating Northrop Grumman.
Northrop Grumman Corporation
Concentrix CorporationConcentrix reported Q3 revenue below expectations and cut its Q4 and full-year 2026 revenue outlook.
GameStop Corp.CEO Ryan Cohen disclosed an open-market purchase of 450,000 Class A shares for about $10.6 million, lifting his ownership to 8.8%.
Moderna IncCiti downgraded Moderna to Sell, saying the valuation had become stretched after a run to a new 52-week high.
Citigroup Inc.
Micron Technology Inc
Richardson Electronics Ltd
Yirendai Ltd